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Ryanodine receptor and capacitative Ca21 entry in fresh preglo- solic Ca21 ([Ca21]i) in intact vessels or vascular smooth
merular vascular smooth muscle cells. muscle cells (VSMCs) derived from afferent arterioles
Background. A multiplicity of hormonal, neural, and para- [1–5]. More recently, calcium mobilization from intracel-crine factors regulates preglomerular arterial tone by stimulat-
lular stores has been well documented in renal resistanceing calcium entry or mobilization. We have previously provided
vessels [3, 6–10]. Furthermore, we have shown that ca-evidence for capacitative (store-operated) Ca21 entry in fresh
renal vascular smooth muscle cells (VSMCs). Ryanodine-sensi- pacitative (store-operated) calcium entry is present in
tive receptors (RyRs) have recently been identified in a variety fresh VSMCs derived from rat preglomerular vessels [6].
of nonrenal vascular beds. Physiologic Ca21 release from the sarcoplasmic reticu-Methods. We isolated fresh rat preglomerular VSMCs with
lum (SR) can be stimulated by two mechanisms: (1) ana magnetized microsphere/sieving technique; cytosolic Ca21
inositol triphosphate (IP3) receptor that is inhibited by([Ca21]i) was measured with fura-2 ratiometric fluorescence.
Results. Ryanodine (3 mmol/L) increased [Ca21]i from 79 to heparin, and (2) a ryanodine-sensitive receptor that is
138 nmol/L (P 5 0.01). Nifedipine (Nif), given before or after stimulated by Ca21 and is sensitive to the plant alkaloid
ryanodine, was without effect. The addition of calcium (1
ryanodine, to caffeine, and to adenosine triphosphatemmol/L) to VSMCs in calcium-free buffer did not alter resting
(ATP) [11]. Ryanodine-sensitive receptors (RyR) have[Ca21]i. In Ca-free buffer containing Nif, [Ca21]i rose from 61
to 88 nmol/L after the addition of the Ca21-ATPase inhibitor been studied extensively in skeletal and cardiac muscle.
cyclopiazonic acid and to 159 nmol/L after the addition of Ca21 More recently, investigators have identified functional
(1 mmol/L). Mn21 quenched the Ca/fura signal, confirming RyR in a wide variety of large conduit and small resis-
divalent cation entry. In Ca-free buffer with Nif, [Ca21]i in- tance arteries, namely, aortic, cerebral, femoral, coro-creased from 80 to 94 nmol/L with the addition of ryano-
nary, pulmonary, and mesenteric [12–22]. RyRs have notdine and further to 166 nmol/L after the addition of Ca21
(1 mmol/L). Mn21 quenching was again shown. Thus, emptying been identified either functionally or anatomically in the
of the sarcoplasmic reticulum (SR) with ryanodine stimulated renal vasculature. Because preliminary work in our labo-
capacitative Ca21 entry. ratory led us to believe that intracellular pathways forConclusion. Preglomerular VSMCs have functional RyR,
calcium mobilization other than the classic IP3 receptorand a capacitative (store-operated) entry mechanism is acti-
model might be operative in fresh preglomerularvated by the depletion of SR Ca21 with ryanodine, as is the
case with inhibitors of SR Ca21-ATPase. VSMCs, we tested the hypothesis that the RyR is pres-
ent. Our goal was to identify functional RyR and to
determine whether stimulation of RyR with caffeine or
A multiplicity of hormonal, neural, and paracrine fac- ryanodine leads to emptying of the SR and activation of
tors regulates arterial tone in preglomerular resistance capacitative calcium entry.
vessels ultimately controlling the glomerular filtration
rate, sodium reabsorption, and blood pressure. Calcium
METHODSentry via voltage-gated L-type channels has been thought
Preparation of preglomerular resistance vesselsto be the predominant mechanism for increasing cyto-
We used a magnetized polystyrene microsphere-siev-
ing technique previously described in our laboratory
Key words: store-operated calcium entry, afferent arteriole, kidney,
[6, 23] to isolate preglomerular vessels (,50 mmol/L insarcoplasmic reticulum, manganese, nifedipine, glomerular filtration
rate, L-type channels. diameter) from six- to seven-week-old Wistar Kyoto rats
maintained in the Chapel Hill Colony. After intraperito-Received for publication November 29, 1999
neal administration of sodium pentobarbital, a midlineand in revised form March 7, 2000
Accepted for publication May 4, 2000 incision exposed the abdominal aorta, which was cannu-
lated below the renal arteries. The aorta was occludedÓ 2000 by the International Society of Nephrology
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above the renal arteries. The left renal vein was incised, calcium. The [Ca21]i was calculated according to this
formula:and the kidneys were perfused slowly with 20 to 40 mL of
cold phosphate-buffered saline (PBS), with the following
[Ca21]i 5 [(R 2 Rmin)/(Rmax 2 R)] · (Sf/Sb) · Kdcomposition in mmol/L: 137 NaCl, 2.7 KCl, 0.88 KH2PO4,
6.4 Na2HPO4, 1.0 MgCl2, adjusted to pH 7.4 at 48C. Three where R is the ratio of the 340/380 nm fluorescence
signal. Rmax is the 340/380 ratio in the presence of satura-milliliters of a suspension of magnetized microspheres
(Spherotech, Libertyville, IL, USA) in cold PBS were tion calcium. Rmin is the 340/380 ratio in calcium free
buffer containing 10 nmol/L EGTA, and Sf/Sb is the ratiothen infused. Thin cortical slices were minced and ho-
mogenized, and preglomerular arterioles were separated of the 380 nm fluorescence measured in a calcium-free
buffer to that measured in a calcium-replete solutionfrom the crude homogenate with a magnet. Passage of
the suspension through needles of decreasing size dis- [24]. For Mn21 quenching experiments, we quantitated
the fluorescence signal at 360 nm to document that Mn21rupted vessels from their glomeruli. Application of the
suspension to a 120 mm sieve retained vessel segments; did indeed quench the signal [25].
All drugs and chemicals were added in a 5 mL volumethe glomeruli and other debris were washed through the
sieve and were discarded. The microvessels were washed to the droplet of cells on the surface of a cover slip. To
study the identical cell(s) with sequential drug additions,from the inverted sieve, further purified with another
magnet separation, and finally treated with collagenase we did not wash the cells between additions in order not
to dislodge them from their position on the glass cover(type 1-A, 0.03 to 0.04%; Sigma, St. Louis, MO, USA)
for 20 minutes at 378C. The suspension was chilled and slip. Calculations of drug concentration were based on
the changing volumes of the droplet on the cover slip.then shaken vigorously to disrupt the vessels. Cells were
incubated in Hank’s buffered salt solution (HBSS; in To minimize problems with evaporation, we limited our
observation time to 250 seconds or less. During this ob-mmol/L: 137 NaCl, 5.4 KCl, 0.33 Na2HPO4, 0.44 KH2PO4,
5 glucose, 1.0 MgCl2) containing 2 mmol/L fura-2-AM servation period, control studies showed that there was
no change in counts at 340 and 380 nm as well as thefor 45 to 60 minutes at room temperature in the dark.
After washing twice with HBSS, cells were kept on ice ratio of the two.
either in HBSS with 1 mmol/L MgCl2 and 0.5 mmol/L
ProtocolEGTA (Ca21 free, ,20 nmol/L, measured) or HBSS
with 1.0 mmol/L MgCl2 and 1.0 mmol/L CaCl2. Unless otherwise stated, VSMCs were prepared in
nominally calcium-free buffer (approximately 3.5 h from
Measurement of cytosolic free calcium concentration harvesting of the kidneys to measuring Ca21). The [Ca21]
of the buffer was measured as approximately 200 nmol/L,We measured cytosolic free calcium concentration
([Ca21]i) as previously described [6, 23, 24]. A suspension whereas that of buffer containing EGTA was ,20 nmol/L.
To demonstrate capacitative calcium entry, emptying ofof VSMCs (10 mL) was gently aspirated from the surface
of the cell pellet and spread on a cover slip, which was the SR was achieved either by stimulating with angioten-
sin II (Ang II) to activate the IP3 pathway or by inhibitingplaced in the optical field of a 340 oil-immersion fluo-
rescence objective of an inverted microscope (Olympus the sarcolemmal Ca21-ATPase with cyclopiazonic acid
(CPA). To prevent calcium entry via voltage-gated L-typeIX70). VSMCs, identified morphologically by their spin-
dle or crescent shape, have been shown previously to channels, cells were treated with nifedipine (Nif). Cal-
cium was added to the bathing buffer to restore extracel-stain with smooth muscle specific a-actin and heavy chain
myosin SM-1 and SM-2 [23]. Care was taken to focus lular Ca21 to normal (1 mmol/L) to permit Ca21 entry
to occur. Alternatively, Mn21 replaced Ca21 or was addedon and record from one to three VSMCs. Not infre-
quently, two VSMCs were adherent to each other. HBSS subsequent to Ca21 to document divalent cation entry.
Because Mn21 quenches the Ca/fura signal, it serves as(5 mL) was then added to ensure that the cells were
adhering to the cover slip and would not be washed a marker for the entry of the divalent cations.
Ryanodine closes the RyR at high concentrationsaway by additions of drugs. The VSMCs were excited
alternately with light of 340 and 380 nm wavelength from (.100 mmol/L); therefore, we employed concentrations
of ,5 mmol/L to stimulate the RyR. The experimentala dual-excitation wavelength Delta-Scan equipped with
dual monochronometers and a chopper [Photon Tech- design for identifying the activation of the capacitative
entry pathway by ryanodine was identical to that de-nology International (PTI), South Brunswick, NJ, USA].
After passing signals through a barrier filter (510 nm), scribed previously in this article.
fluorescence was detected by a photomultiplier tube.
ReagentsSignal intensity was acquired, stored, and processed by
an IBM-compatible Pentium II computer and Felix soft- Collagenase, Ang II, EGTA, caffeine, and Nif came
from Sigma. CPA and ryanodine came from Cal Bio-ware (PTI). The calibration of [Ca21]i was based on the
signal ratio at 340/380 nm and known concentrations of chem (La Jolla, CA, USA). Vasopressin-1 receptor ago-
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nist ([Phe2, Ile3, Orn8]-Vasopressin) (V1R) was from Pen-
insula Laboratories (Belmont, CA, USA), and Fura-2-
AM came from Molecular Probes (Eugene, OR, USA)
or Teflab (Austin, TX, USA).
Statistics
The data are presented as means 6 SEM. Each data
set is derived from VSMCs originating from at least three
separate experimental days, two to three rats (4 to 6
kidneys) per experiment. Individual cells were studied
only once and were then discarded. The data sets were
tested with Student’s paired t-test. Multiple comparisons
were analyzed using one-way analysis of variance for
repeated measures followed by the Student–Neuman–
Kuels post hoc test. P , 0.05 was considered statistically
significant.
RESULTS
Stimulation of VSMCs with the peptide agonists Ang
II or V1R typically produced a nearly square wave mor-
phology of the [Ca21]i response, characterized by an im-
mediate step increase that was generally somewhat sus-
tained during the period of stimulation. This was
particularly apparent in time-averaged group plots,
which persisted during the 50-second period of observa-
tion. In a minority of cases, an initial sharp peak of a
few seconds’ duration was seen. We and others have
noted this square-shaped pattern of response in healthy
fresh VSMCs and vessel segments, microdissected affer-
ent arterioles, and mesenteric artery of the rat and rabbit
in response to Ang II, vasopressin, norepinephrine as
well as KCl [6, 9, 23, 26–33].
Because both caffeine (10 mmol/L) and ryanodine (1
Fig. 1. Response of preglomerular vascular smooth muscle cellsto 10 mmol/L) are known to stimulate the RyR in skeletal
(VSMCs) to ryanodine (3 mmol/L). (A) Group averages for stimulatory
muscle and nonrenal vascular smooth muscle by opening effect of ryanodine on cytosolic calcium in VSMCs (N 5 8, P , 0.01).
Means 6 SEM are shown. (B) Representative original tracing showingthe RyR channel and permitting passage of Ca21 from
the lack of additive effect of ryanodine on VSMCs first stimulated withthe SR to the cytosol [34–36], we conducted experiments
caffeine (10 mmol/L).
to test their effect on mobilization of Ca21 from the SR
in preglomerular VSMCs. Since high concentrations of
ryanodine (1 mmol/L) close the RyR, choice of an experi-
mental concentration of ryanodine is important. In con- should not be additive. To demonstrate further the speci-
trol studies, comparing the effects of 3 and 30 mmol/L ficity of ryanodine for the RyR, we treated cells first
concentrations of ryanodine, the stimulatory dose of rya- with caffeine, followed by the addition of ryanodine. In
nodine (3 mmol/L) increased [Ca21]i from 57 6 8 to 109 6 our preglomerular VSMCs, caffeine (10 mmol/L) in-
10 nmol/L (N 5 6, P , 0.01). In contrast, 30 mmol/L creased [Ca21]i from 78 6 6 to 134 6 12 nmol/L (N 5
ryanodine were without effect; baseline [Ca21]i was 59 6 10, P , 0.01). The subsequent addition of ryanodine
8 nmol/L, and following the addition of 30 mmol/L, rya- (2 mmol/L) did not change [Ca21]i (124 6 10 nmol/L,
nodine was 64 6 7 nmol/L (N 5 6, P 5 0.4). Figure 1A P . 0.4). A representative tracing is shown in Figure 1B.
shows the group-averaged response of fresh preglomeru- The ability of the RyR to increase arterial wall [Ca21]i
lar VSMCs to ryanodine (3 mmol/L) in calcium-con- has been shown to be blocked by inhibition of L-type
channels with nimodipine in pressurized carotid arteriestaining buffer (1 mmol/L). Cytosolic calcium rose from
79 6 10 to 138 6 18 nmol/L (N 5 8, P , 0.01). Because [36]. To evaluate whether this is the case in renal VSMCs,
we studied the effect of ryanodine on preglomerularboth caffeine (10 mmol/L) and ryanodine (1 to 10
mmol/L) maximally activate a common RyR, their effects VSMCs when L-type Ca21 channels were blocked by Nif
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Fig. 2. Two sets of experiments showing the lack of effect of nifedipine
(Nif, 1027 mol/L) on the cytosolic calcium response of VSMCs to ryano-
dine. Neither Nif given after stimulation of VSMCs with ryanodine (left
bars) nor pretreatment with Nif (right bars) altered the response to
ryanodine (N 5 6 in both groups).
(1027 mol/L). Dihydropyridine calcium channel blockers
(CCBs) at a concentration of 1027 mol/L have been
shown to completely inhibit potassium-stimulated 45Ca
uptake and to reverse potassium-mediated reductions in
renal plasma flow [36, 37]. We have previously demon-
strated that CCBs at this concentration inhibit by 50%
the global response of renal VSMCs to arginine vaso-
pressin [6]. Figure 2 shows that neither pretreatment
nor post-treatment with Nif (1027 mol/L) influenced the
stimulatory effect of ryanodine on renal VSMCs. In the Fig. 3. Control experiments showing the lack of effect of external Ca21
presence of Nif, ryanodine increased [Ca21]i from 58 6 (1 mmol/L) and Mn21 (1 mmol/L) on resting [Ca21]i in VSMCs pre-
viously maintained in a nominally calcium-free buffer. (A) Sequential12 to 96 6 14 (N 5 6, P , 0.01). In the absence of Nif,
addition of Ca 21 and agonist (N 5 9, P . 0.8 for Ca21 vs. calcium-[Ca21]i rose from 53 6 9 to 104 6 13 following the free, P , 0.01 for Ca 21 vs. agonist). (B) Addition of external Mn21
stimulation with ryanodine (N 5 6, P , 0.01). Subse- (N 5 12, P . 0.6).
quent addition of Nif was without effect (102 6 14, N 5
6, P . 0.7 for comparison of the effect of ryanodine with
or without Nif).
they were then stimulated with a variety of agonists (AngBefore evaluating the possible role of ryanodine-stim-
II, V1R, and KCl), which consistently increased [Ca21]i.ulated depletion of SR Ca21 in activating capacitative
Manganese (1 mmol/L) likewise did not alter resting(store-operated) entry in preglomerular VSMCs, we per-
[Ca21]i in VSMCs (Fig. 3B). Baseline [Ca21]i was 97 6formed control experiments to examine the effect (or
7 nmol/L and did not change after the addition of Mn21lack thereof) of adding Ca21 or Mn21 to VSMCs pre-
(90 6 7 nmol/L, N 5 12, P . 0.7).viously maintained in nominally calcium-free buffer. Fig-
As Figure 4A shows, stimulation of VSMCs with Angure 3A is a composite of nine experiments in which Ca21
II in calcium-free buffer containing 0.5 mmol/L EGTA(1 mmol/L) was added to VSMCs previously exposed to
and Nif (1027 mol/L) immediately caused a rapid andcalcium-free medium for approximately 3.5 hours. The
sustained increase in [Ca21]i from 72 6 9 to 101 6 6[Ca21]i of VSMCs in calcium-free buffer and that follow-
nmol/L (P , 0.001), indicating that Ang II mobilizesing the addition of Ca21 were not different. Thus, extra-
Ca21 from intracellular stores as we have previouslycellular calcium alone, in the absence of agonist, does
shown for V1R [6, 7]. The addition of Ca21 (1 mmol/L)not significantly change [Ca21]i in healthy preglomerular
VSMCs. To ensure that these were indeed viable cells, to the extracellular buffer caused a step increase in
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Fig. 4. Cytosolic calcium concentration ([Ca21]i) in VSMCs freshly derived from preglomerular arterioles in calcium-free buffer containing EGTA
(0.5 mol/L) and Nif (1027 mol/L). (A) Effect of treatment with Ang II (1027 mol/L) followed by the addition of Ca21 (1 mmol/L) and then Mn21
(approximately 1 mmol/L). The results are means 6 SEM for seven experiments (P , 0.001 for each comparison). (B) VSMCs treated with
angiotensin II (Ang II, 1027 mol/L). Fluorescence in counts per second at 360 nm. The sequential addition of Ca21 (1 mmol/L) and Mn21
(approximately 1 mmol/L, N 5 7). (C) Group results for the sequential addition of cyclopiazonic acid (CPA, 1026 mol/L) and Ca21 (1 mmol/L).
The subsequent addition of Mn21 (approximately 1 mmol/L) quenched the Ca21/fura signal (N 5 7, P , 0.001 for all comparisons). Results are
means 6 SEM. (D) Representative tracing continued for 300 seconds to illustrate the decline of the ratio of 340/380 nm with time following the
addition of Mn21.
[Ca21]i to 152 6 10 nmol/L (P , 0.001). The Ca21/fura These data demonstrate that Ang II-initiated Ca21 mobi-
lization activates capacitative (store-operated) Ca21 in-signal was then quenched by the addition of Mn21 (ap-
proximately 1 mmol/L, N 5 7, P , 0.001). Evidence for flux mechanisms in preglomerular VSMCs. They extend
our previous findings that AVP V1 receptor agonist stim-store-operated calcium entry in response to Ang II has
not previously been demonstrated in preglomerular re- ulates capacitative entry in renal resistance vessels [6].
To substantiate further the operation of capacitativenal VSMCs. In Mn21 quenching experiments, fluores-
cence at 360 nm was quantitated [25] to show that at the Ca21 entry in VSMCs derived from renal-resistance ar-
teries and arterioles, we employed the Ca21-ATPase in-isobestic point, the signal did not change after a rise in
[Ca21]i, but fell after the addition of Mn21 to the bathing hibitor CPA (1026 mol/L), which depletes intracellular
Ca21 stores by preventing reaccumulation of calcium intobuffer corroborating divalent cation entry (Fig. 4B).
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the SR [38]. In these experiments, baseline [Ca21]i in cium influx following the depletion of SR calcium with
ryanodine has not previously been demonstrated inEGTA-calcium free buffer rose from 61 6 7 to 88 6 9
nmol/L following the addition of CPA and to 159 6 15 smooth muscle cells in any vascular tissue.
Store-operated or capacitative calcium entry is thatnmol/L when Ca21 (1 mmol/L) was added to the buffer
(N 5 7, P , 0.01 for each intervention). Subsequent process by which depletion of calcium in the endoplasmic
or SR stimulates the opening of a divalent cation chan-addition of extracellular Mn21 quenched the Ca21/fura
signal, further demonstrating that depletion of calcium nel(s) in the plasmalemmal membrane, which permits
the entry of Ca21 or Mn21 [43–45]. This entry channelfrom the SR stimulated opening of a divalent ion entry
channel that persists for at least 50 seconds (Fig. 4C). is inhibited by Gd31 and is distinct from voltage-gated
L-type channels and from arachidonic acid metabolite-In several experiments, which were carried out for longer
periods of time, the ratio of counts per second at 340/ stimulated calcium entry [46]. Our studies show that
stimulation of VSMCs with Ang II or with V1R [6] mobi-380 nm following addition of Mn21 continued to decline
(Fig. 4D). lized Ca21 from the SR in calcium-free buffer containing
CCB to block voltage-gated L-type channels. The subse-Studies were conducted to determine whether ryano-
dine stimulation of calcium release from the SR would quent addition of calcium to the extracellular buffer in-
creased [Ca21]i through influx of Ca21 via the putativetrigger store-operated Ca21 entry. In these experiments,
we used Nif to block possible entry via voltage-gated capacitative entry pathway. The addition of extracellular
Mn21 quenched the Ca21/fura signal, demonstrating thatL-type channels. When VSMCs in calcium-free buffer
containing Nif (1027 mol/L) were stimulated with rya- a divalent cation channel had been opened to permit
Mn21 entry. Control experiments established that Mn21nodine (3 mmol/L), [Ca21]i increased from 80 6 10 to
94 6 10 nmol/L (P , 0.001); a subsequent addition of does not enter the cytosol under basal conditions when
the divalent cation channels are inactive. Likewise, treat-Ca21 (1 mmol/L) caused a step increase to 166 6 11
nmol/L (N 5 9, P , 0.001). These data show that ryanod- ment of VSMCs in calcium-free buffer containing Nif
(to block voltage-gated L-type channels) and the Ca21-ine-induced depletion of SR Ca21 promoted the opening
ATPase inhibitors CPA (Fig. 4C) or thapsigargin [6],of a channel distinct from an L-type channel. That Mn21
prevented refilling of the SR with Ca21, activated thequenched the Ca21/fura signal further substantiates the
store-operated pathway that opened divalent cationopening of a divalent cation channel insensitive to Nif
channels, and permitted an influx of Ca21 when calcium(Fig. 5A). Figure 5B shows the data for studies done in
was added to the extracellular buffer. It is highly unlikelythe absence of Nif. Ryanodine (3 mmol/L) increased
that sodium/calcium exchange, operating in the reverse[Ca21]i from 61 6 7 to 78 6 5 nmol/L, which then rose
direction [47], could be responsible for calcium entryto 141 6 18 nmol/L when Ca21 (1 mmol/L) was added
under our experimental conditions. Sodium concentra-to the buffer (N 5 9, P , 0.001 for both). Mn21 quenched
tion in the extracellular compartment was not loweredthe Ca21/fura signal as before (Fig. 5C). It is noteworthy
nor were drugs that increase intracellular sodium given.that the increase in [Ca21]i was similar whether or not
Ryanodine (2 to 3 mmol/L, a concentration knownNif was present, confirming our earlier results showing
to stimulate RyR) [17] and caffeine (10 mmol/L) boththat store-operated Ca21 occurs via channel distinct from
increased [Ca21]i by stimulating release of Ca21 from theone that is dyhydropyridine sensitive.
SR. At these concentrations, ryanodine and caffeine are
specific for the RyR and do not have an effect on IP3
DISCUSSION receptors of the SR in VSMCs [11]. Ryanodine, like CPA
We have established, to our knowledge for the first or thapsigargin, depleted intracellular calcium stores and
time, the presence of a functional RyR in fresh VSMCs thus promoted calcium entry via a capacitative pathway.
isolated from preglomerular arterioles. The RyR of the The RyRs of skeletal and cardiac muscle have been
SR exists in a number of different subtypes in skeletal extensively studied [35]. However, the identification and
and cardiac muscle [35]. More recently, RyR subtypes functional characterization of the RyR Ca21-gated Ca21
have been identified in nonexcitable cells [39–41] and release channel in VSMCs have only more recently been
nonrenal VSMCs [12–22, 42, 43]. Furthermore, we are achieved [11]. Like the skeletal and cardiac muscle sub-
the first to show that depleting SR Ca21 by stimulation types, RyR in aortic VSMCs is activated by mmol/L con-
of the RyR with ryanodine promotes calcium influx via centrations of ryanodine, activated by caffeine (mmol/L
a store-operated or capacitative mechanism [43–45]. range), inhibited by Mg21 (.2 mmol/L), and inhibited
These data along with those obtained with CPA and by ruthenium red (mmol/L) [15]. A wide variety of both
with Ang II in the present study extend our previous conduit and resistance arteries contain RyR [12–22, 42,
observations with vasopressin V-1 receptor agonist and 43]. In studies conducted on rings of large arteries,
thapsigargin that a capacitative pathway exists in preglo- smaller resistance arteries and submucosal ileal art-
erioles, functional RyRs were found to be present atmerular VSMCs [6]. To our knowledge, capacitative cal-
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Fig. 5. Temporal calcium response to ryanodine (3 mmol/L) stimula-
tion of preglomerular VSMCs. (A) In calcium-free buffer containing
EGTA (0.5 mol/L) and Nif (1027 mol/L), response to sequential addition
of ryanodine, Ca21 (1 mmol/L) and Mn21 (approximately 1 mmol/L,
N 5 9, P , 0.001 for all). (B) Response to ryanodine without Nif
present, followed by the addition of external Ca21 and then Mn21 (N 5
9, P , 0.001). (C) VSMCs stimulated by ryanodine in calcium-free
buffer. Fluorescence in counts per second at 360 nm. The sequential
addition of Ca21 (1 mmol/L) had no effect on counts per second at the
isobestic wave length for Ca/fura; Mn21 significantly quenched the signal
(approximately 1 mmol/L). Data are means 6 SEM (P after addition
of Mn21, P , 0.01).
all levels of the vasculature; however, the contribution creased the activity of KCa channels. Also, the CCBs
nimodipine and diltiazem (1028 mol/L) decreased cal-of the SR to the maintenance of vascular contractility
appeared to diminish with decreasing caliber of the ves- cium sparks, demonstrating the voltage dependence of
the sparks. Our studies were geared toward studyingsel [48].
Coupling of RyR to calcium entry via a store-operated calcium entry mechanisms rather than the process of
hyperpolarization generated by calcium sparks and KCamechanism has been suggested in studies with caffeine
and thapsigargin in the excitable cell line of PC 12 cells channels. We used both verapamil and Nif (1027 mol/L)
to inhibit effectively and selectively the voltage-gated[40]. Evidence for capacitative calcium influx was sought
in the embryonic aortic A7r5 cells in culture, but was L-type channels and found that the stimulatory effect
of ryanodine on the SR was not influenced by thesenot found [43]. We have not identified any study in which
capacitative entry linked to ryanodine-stimulated empty- maneuvers.
Cyclic ADP ribose (cADPR), a recently identified nu-ing of the SR has been proven to be operative in a blood
vessel of any origin or caliber. cleotide that is known to stimulate the RyR to release
Ca21 from the SR, is synthesized from b-NAD with theRyanodine-sensitive receptors have been investigated
in intact pressurized cerebral arteries and fresh VSMCs enzyme ADP-ribosyl cyclase [51]. It has been suggested
that cADPR acts as a second messenger to release Ca21enzymatically derived from these arteries [36, 49, 50].
Ryanodine, by increasing [Ca21]i, diminished the fre- from the SR via the RyR pathway [51, 52]. Rat glomeruli,
cultured mesangial cells, and cultured aortic VSMCsquency of calcium sparks in these studies and thus de-
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